MHRA Class 2 Medicines Recall: Levothyroxine 12.5mcg Tablets (Teva UK Limited)
Drug alert number: EL(23)A/06
Date issued: 2 March 2023
The Medicines and Healthcare products Regulatory Agency (MHRA) has issued a class 2 medicines recall for: Levothyroxine 12.5mcg Tablets (Teva UK Limited) – PL 00289/1971
|Batch Number||Expiry Date||Pack Size||First Distributed|
|214052||10 2023||28 tablets||20 July 2022|
Active Pharmaceutical Ingredients: Levothyroxine Sodium
Brief description of the problem
Teva UK Limited is recalling the above batch of Levothyroxine 12.5mcg Tablets in response to a lower than required assay result discovered during routine stability testing.
Advice for healthcare professionals
Stop supplying the above batch immediately. Quarantine all remaining stock and return it to your supplier using your supplier’s approved process.
Full drug alert can be viewed here.
For any Levothyroxine stock enquiries please contact the Teva UK Limited Customer Solutions team on 0800 590 502.
For more information or medical enquiries, please contact Teva UK Limited by phone on 020 7540 7117 or by email to email@example.com